Is Macro Bank Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: BMA) stock is to Strong Buy BMA stock.
Out of 2 analysts, 2 (100%) are recommending BMA as a Strong Buy, 0 (0%) are recommending BMA as a Buy, 0 (0%) are recommending BMA as a Hold, 0 (0%) are recommending BMA as a Sell, and 0 (0%) are recommending BMA as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year BMA price target, the average BMA price target is $91.50, with the highest BMA stock price forecast at $98.00 and the lowest BMA stock price forecast at $85.00.
On average, Wall Street analysts predict that Macro Bank's share price could fall to $91.50 by May 5, 2027. The average Macro Bank stock price prediction forecasts a potential downside of 6.54% from the current BMA share price of $97.90.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.